Key Points
- Heartflow CFO Vikram Verghese sold 6,640 shares for $332,199 at an average price of $50.03, reducing his direct ownership by 3% to 214,503 shares. The transaction occurred under a pre-arranged Rule 10b5-1 trading plan, following two other sales earlier in September.
- Heartflow recently reported stronger-than-expected quarterly results, with an EPS loss of $0.07 versus analysts’ expected loss of $0.22 and revenue of $64.08 million, up 47.7% year over year. Despite the revenue growth, the company posted a negative net margin of 55.82%.
- HTFL was trading near $45.49, below its 52-week high of $51.78, while analysts maintained an overall “Moderate Buy” rating with an average price target of $44.88.
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CFO Vikram Verghese sold 6,640 shares of the business's stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $50.03, for a total value of $332,199.20. Following the completion of the transaction, the chief financial officer directly owned 214,503 shares in the company, valued at approximately $10,731,585.09. This trade represents a 3.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Vikram Verghese also recently made the following trade(s):
- On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The stock was sold at an average price of $49.69, for a total transaction of $1,368,462.60.
- On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The stock was sold at an average price of $50.60, for a total transaction of $297,325.60.
Heartflow Trading Down 2.5%
HTFL opened at $45.49 on Friday. The company has a fifty day moving average price of $35.08 and a two-hundred day moving average price of $30.65. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $51.78. The company has a market cap of $3.96 billion and a P/E ratio of -24.86.
Heartflow (NASDAQ:HTFL - Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.22) by $0.15. The company had revenue of $64.08 million for the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. Heartflow's revenue was up 47.7% on a year-over-year basis. On average, research analysts forecast that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.
Hedge Funds Weigh In On Heartflow
A number of hedge funds have recently added to or reduced their stakes in HTFL. Caitong International Asset Management Co. Ltd bought a new stake in Heartflow during the 4th quarter worth approximately $27,000. Russell Investments Group Ltd. bought a new position in shares of Heartflow in the fourth quarter valued at approximately $45,000. Legal & General Group Plc bought a new position in shares of Heartflow in the third quarter valued at approximately $59,000. Integrated Wealth Concepts LLC purchased a new position in shares of Heartflow during the second quarter valued at approximately $53,000. Finally, Essential Partners LLC bought a new stake in Heartflow during the first quarter worth $57,000.
Analysts Set New Price Targets
HTFL has been the topic of several recent research reports. Benchmark reiterated a "buy" rating on shares of Heartflow in a report on Friday, August 14th. Weiss Ratings upgraded Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, August 7th. Canaccord Genuity Group increased their target price on Heartflow from $37.00 to $45.00 and gave the stock a "buy" rating in a report on Friday, August 14th. Freedom Capital upgraded shares of Heartflow to a "strong-buy" rating in a research note on Tuesday, June 30th. Finally, Morgan Stanley upped their price objective on shares of Heartflow from $35.00 to $40.00 and gave the stock an "equal weight" rating in a report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $44.88.
Check Out Our Latest Analysis on Heartflow
Heartflow Company Profile
(
Get Free Report)
HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.
HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
